摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-氨基吡啶-2-甲酰胺 | 50608-99-6

中文名称
3-氨基吡啶-2-甲酰胺
中文别名
3-氨基吡啶-2-酰胺
英文名称
3-aminopyridine-2-carboxamide
英文别名
3-aminopicolinamide;3-amino-pyridine-2-carboxylic acid amide
3-氨基吡啶-2-甲酰胺化学式
CAS
50608-99-6
化学式
C6H7N3O
mdl
MFCD06658329
分子量
137.141
InChiKey
KAAUMYRJIPPSNP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    82
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2933399090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    2-8℃

SDS

SDS:634f86a7eddeddf082d1d1ee01b5f125
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 3-Aminopyridine-2-carboxamide
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 3-Aminopyridine-2-carboxamide
CAS number: 50608-99-6

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H7N3O
Molecular weight: 137.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

用途

3-氨基吡啶-2-甲酰胺是酰胺类衍生物,常用于医药中间体。

上下游信息

反应信息

  • 作为反应物:
    描述:
    3-氨基吡啶-2-甲酰胺盐酸三氯氧磷 作用下, 以 异丙醇 为溶剂, 反应 46.5h, 生成 N-benzylpyrido[3,2-d]pyrimidin-4-amine
    参考文献:
    名称:
    酪氨酸激酶抑制剂。10.异构体4-[((3-溴苯基)氨基]吡啶并[d]-嘧啶是表皮生长因子受体的酪氨酸激酶功能的有效ATP结合位点抑制剂。
    摘要:
    在发现4-[(3-溴苯基)氨基]-喹唑啉具有极高的抑制表皮生长因子受体(EGFR)酪氨酸激酶活性的能力(例如3,IC50为0.029 nM)之后,合成并评估了在6或7位带有供电子基团的相关吡啶并[d]嘧啶。通过亲核取代相应的6-和7-氟类似物来制备化合物。尽管所有系列成员均显示出对分离的EGFR的有效抑制活性,但不同的异构吡啶并[d]嘧啶与母体喹唑啉之间存在重要差异。总的来说,[3,4-d]和[4,3-d]系列是最有效的,其次是[3,2-d]化合物,[2,3-d]类似物的活性最低。在母体喹唑啉系列中,向6-或7-NH2取代基(即NHMe和NMe2基团)中增加空间位阻会显着降低效能,而在[3,2-d]系列中则没有这种趋势。此外,在7-取代的吡啶并[4,3-d]-和6-取代的吡啶并[3,4-d]嘧啶系列中,并且在有限的程度上在7-取代的吡啶并[2,3-d]系列中,这样的取代作用显着提高了效力,其程度为7-(甲基氨基)吡啶并[4
    DOI:
    10.1021/jm9508651
  • 作为产物:
    参考文献:
    名称:
    Rasala, D., Bulletin de la Societe Chimique de France, 1992, # 1, p. 79 - 84
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Method of treating a patient having precancerous lesions with phenyl
    申请人:Cell Pathways, Inc.
    公开号:US06060477A1
    公开(公告)日:2000-05-09
    Derivatives of Phenyl Cycloamino Pyrimidinone are useful for the treatment of patients having precancerous lesions. These compounds are also useful to inhibit growth of neoplastic cells.
    苯基环氨基嘧啶酮的衍生物对于治疗患有癌前病变的患者是有用的。这些化合物还可用于抑制肿瘤细胞的生长。
  • Chemical compounds
    申请人:Smith Kline & French Laboratories, Ltd.
    公开号:US05047404A1
    公开(公告)日:1991-09-10
    This invention relates to fused pyrimidine derivatives which have bronchodilator and anti-allergic activities. A compound of the invention is 2-(2-propoxyphenyl)pyrido[2,3-d]pyrimid-4(3H)-one.
    这项发明涉及具有支气管扩张剂和抗过敏活性的融合嘧啶衍生物。该发明的化合物是2-(2-丙氧基苯基)吡啶并[2,3-d]嘧啶-4(3H)-酮。
  • Bicyclic compounds capable of inhibiting tyrosine kinases of the
    申请人:Warner-Lambert Company
    公开号:US05654307A1
    公开(公告)日:1997-08-05
    Novel 4-substituted amino pyrido pyrimidine and 4-substituted amino pyrido pyrimidine inhibitors of epidermal growth factor receptor family of tyrosine kinase are described, as well as pharmaceutical compositions of the same, which are useful in treating proliferative diseases such as cancer, synovial pannus invasion in arthritis, psoriasis, vascular restenosis and angiogenesis and additionally useful in the treatment of pancreatitis and kidney disease as well as a contraceptive agent.
    描述了新型4-取代氨基吡啶嘧啶和4-取代氨基吡啶嘧啶抑制剂对表皮生长因子受体家族的酪氨酸激酶的作用,以及相应的药物组合物,这些药物在治疗癌症、关节炎中的滑膜侵袭、牛皮癣、血管再狭窄和血管生成方面非常有用,此外还可用于治疗胰腺炎和肾病,以及作为避孕药剂。
  • [EN] CARBOXAMIDE INHIBITORS OF IRAK4 ACTIVITY<br/>[FR] CARBOXAMIDES UTILISÉS COMME INHIBITEURS DE L'ACTIVITÉ DE L'IRAK4
    申请人:MERCK SHARP & DOHME
    公开号:WO2016144844A1
    公开(公告)日:2016-09-15
    The present invention relates to carboxamide inhibitors of IRAK4 of formula (I) and provides compositions comprising such inhibitors, as well as methods therewith for treating IRAK4-mediated or -associated conditions or diseases.
    本发明涉及式(I)的IRAK4的羧酰胺抑制剂,并提供包含这种抑制剂的组合物,以及用于治疗IRAK4介导或相关疾病或疾病的方法。
  • [EN] NOVEL KINASE INHIBITORS<br/>[FR] NOUVEAUX INHIBITEURS DE KINASES
    申请人:ORIGENIS GMBH
    公开号:WO2014060113A1
    公开(公告)日:2014-04-24
    The present invention relates to novel compounds of formula (I) that are capable of inhibiting one or more kinases, especially SYK (Spleen Tyrosine Kinase), LRRK2 (Leucine-rich repeat kinase 2) and/or MYLK (Myosin light chain kinase) or mutants thereof. The compounds find applications in the treatment of a variety of diseases. These diseases include autoimmune diseases, inflammatory diseases, bone diseases, metabolic diseases, neurological and neurodegenerative diseases, cancer, cardiovascular diseases, allergies, asthma, alzheimer's disease, parkinson's disease, skin disorders, eye diseases, infectious diseases and hormone-related diseases.
    本发明涉及一种具有公式(I)的新化合物,能够抑制一个或多个激酶,特别是SYK(脾酪氨酸激酶)、LRRK2(富含亮氨酸重复的激酶2)和/或MYLK(肌球蛋白轻链激酶)或其突变体。这些化合物在治疗多种疾病中发挥作用。这些疾病包括自身免疫疾病、炎症性疾病、骨疾病、代谢性疾病、神经和神经退行性疾病、癌症、心血管疾病、过敏、哮喘、阿尔茨海默病、帕金森病、皮肤疾病、眼部疾病、传染病和激素相关疾病。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-